Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Dzhus, Marta; Masnyi, Marta; Kulyk, Myroslava; Mostbauer, G. V.; Ivashkivsky, Oleksiy; Boyko, Yaryna; Cherchenko, Kateryna; Geerinck, Anton; Reginster, Jean‐Yves; Bruyère, Olivier; Beaudart, Charlotte

doi:10.4235/agmr.20.0020

Cited by 13 publications

(13 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The SARCPH study showed a decrease in QoL areas, especially physical functions, among sarcopenic patients [23].In one study, mean SarQoL scores were reported as 58.43±17.13 for Sarcopenic patients and 69.89±13.31 for non-sarcopenic patients [24]. In our study, the mean SarQol total value during the pandemic period was found to be 66.91 ± 14.35. programmes [25].…”

Section: Discussionsupporting

confidence: 47%

COVID-19 quarantine days’ effect on sarcopenic quality of life and psychological status among elderly people

Karlıbel¹,

Aksoy²,

Önen³

2023

ejhh

View full text Add to dashboard Cite

Aim: Social isolation and quarantine practices are recommended to control SARS-Cov-2. During this period, elderly individuals' physical mobility is significantly restricted, which may predispose them to sarcopenia. We aimed to investigate such pandemic restrictions' effects on elderly individuals' sarcopenic quality of life, anxiety and depression. Methods:The open-ended questionnaire study gained access to volunteers online and remotely. The 'Sarcopenic Quality of Life Scale', 'Geriatric Depression Scale-Short Form' and 'Geriatric Anxiety Scale' were used. Data were evaluated prospectively and cross-sectionally. Results:In total, 139 elderly volunteers (≥ 65age; 60% female) were included in the study. Compared to before the pandemic, respondents reports decreases in: arm strength (48.6%), leg strength (65.5%), muscle mass (55.7%), energy (67.9%), physical capacity and flexibility (64.3%), walking frequency (77.5%), walking time (79.6%), walking distance (82.4%), walking speed (88.7%) and step length (83.8%). Among coronavirus disease survivors, sarcopenic quality of life was significantly lower than those not exposed to the coronavirus disease, while depression and anxiety were higher.The 'Sarcopenic Quality of Life Scale' items 3 and 6 alone were significantly better among respondents who exercised. A negative correlation was found between sarcopenic quality of life and anxiety and depression. Conclusion:Our study showed decreased physical functions and sarcopenic quality of life among elderly individuals whose movements were restricted to their homes. This decline was more pronounced among coronavirus disease survivors and patients who had not exercised at home during this period, and it was found to be associated with anxiety and depression.

show abstract

Section: Discussionsupporting

confidence: 47%

COVID-19 quarantine days’ effect on sarcopenic quality of life and psychological status among elderly people

Karlıbel¹,

Aksoy²,

Önen³

2023

ejhh

View full text Add to dashboard Cite

show abstract

Section: Ishii Testmentioning

confidence: 99%

SARC-F and other screening tests for sarcopenia

Bahat

Erdoğan

İlhan

2021

Current Opinion in Clinical Nutrition &Amp; Metabolic Care

View full text Add to dashboard Cite

SARC-F and other screening tests for sarcopenia G€ ulistan Bahat a , Tug ˘ba Erdog ˘an a , and Birkan I ˙lhan bPurpose of review Sarcopenia screening tools can enable clinicians to select individuals for more demanding evaluations, and hence, may facilitate its timely diagnosis and management. The most common recommended screening test is SARC-F, whereas many others are proposed. We aimed to summarize the recent studies and evidence performed on SARC-F and other sarcopenia screening tools. Recent findingsMeta-analysis studies reported that despite having moderate-high specificity, SARC-F has low-moderate sensitivity to detect sarcopenia, which would cause a significant number of individuals having sarcopenia to be unrecognized. Several recent studies aimed to increase sensitivity and utility of SARC-F as a screening tool by i.e., application of lower cut-offs, adding extra-items, and combining with other screening tests. Some of these approaches increased its screening efficacy significantly. In line with its previous studies, SARC-F showed success to predict adverse outcomes in the latest studies as well. Recently, it has also been suggested as a reasonable screening test for frailty. In addition to the long-standing screening tests i.e., anthropometric measures, Ishii Test and Mini Sarcopenia Risk Assessment (MSRA) Questionnaire; new tests, i.e., Taiwan Risk Score for Sarcopenia, Sarcopenia Scoring Assessment Model (SarSA-Mod) and re-purposed tests, i.e., SARQoL questionnaire and fracture risk assessment tool have been investigated as potential screening tests for sarcopenia. Some of these tests performed as well as or superior to standard SARC-F.

show abstract

“…It perhaps needs to be emphasized that at the time of the conception of the SarQoL questionnaire by Beaudart et al, the EWGSOP definition was in use [ 24 , 47 ]. The EWGSOP2 definition for sarcopenia was published in 2019, all SarQoL studies executed thereafter chose to use this updated definition to define sarcopenia in their study population with the exception of Le at al who used the AWGS 2019 definition [ 34 , 39 , 41 , 43 , 48 ].…”

Section: Resultsmentioning

confidence: 99%

Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women

Pap¹,

Kalabiska²,

Balogh³

et al. 2023

BMC Musculoskelet Disord

View full text Add to dashboard Cite

Background Sarcopenia is defined as an age-related progressive and systemic loss of muscle mass and function. World Health Organization (WHO) definition of health-related quality of life (QoL) states that health is considered “a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity”, and a decline in QoL is anticipated in individuals with sarcopenia. Beaudart et al. framed the concept of defining QoL in patients suffering from sarcopenia (SarQoL) based on fundamental procedures of QoL questionnaire development, expert recommendations and studies. The aim of the present study is to evaluate the discriminative power, internal consistency and floor and ceiling effects using data available from a sarcopenia study published recently, where the Hungarian version of the SarQoL questionnaire was also administered. Methods In this cross-sectional study, data from SarQoL questionnaire administered to a postmenopausal sarcopenia study cohort (n = 100) was scrutinized for evaluation of psychometric properties of the questionnaire. Our verification of the psychometric properties consisted of discriminative power analysis, assessment of internal consistency, and floor and ceiling effects. The homogeneity of the SarQoL questionnaire, i.e., its internal consistency was measured using Cronbach’s alpha coefficient. Correlation between the overall and domain SarQoL questionnaire scores and appendicular skeletal muscle mass in sarcopenic individuals was assessed. Furthermore, the difference of SarQoL overall and domain scores between sarcopenic and non-sarcopenic patients was also evaluated. Results The median (interquartile range (IQR)) overall SarQoL questionnaire score was 81.5 (67.1–91.5). There was a statistically significant lower overall SarQoL score comparing sarcopenic and non-sarcopenic subjects median (IQR): 75.3 (62.1–86.3) vs. 83.7 (71.4–92.1); p = 0.041). The sarcopenic subjects showed a statistically significant (p = 0.021) correlation between the overall SarQoL score and appendicular skeletal muscle mass (Spearman’s ϱ = 0.412). The overall Cronbach’s alpha of 0.937 indicated a high internal consistency of the Hungarian version of the SarQoL questionnaire. No floor or ceiling effects were noted in the overall SarQoL questionnaire score. Conclusion In our study on community dwelling outpatient postmenopausal Hungarian women, the overall score of the Hungarian version of the SarQoL questionnaire had significant discriminative power to distinguish between sarcopenic and non-sarcopenic patients, had high internal consistency and no floor or ceiling effects.

show abstract

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Cited by 13 publications

References 23 publications

COVID-19 quarantine days’ effect on sarcopenic quality of life and psychological status among elderly people

COVID-19 quarantine days’ effect on sarcopenic quality of life and psychological status among elderly people

SARC-F and other screening tests for sarcopenia

Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women

Contact Info

Product

Resources

About